Release Date: 05/05/23 10:20 Summary: Initial Director's Interest Notice - A Thom Price Sensitive: No Download Document 188.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%